AI assistant
Sending…
Ginkgo Bioworks Holdings, Inc. — Director's Dealing 2021
Sep 20, 2021
32424_dirs_2021-09-20_dfb2ed22-391d-4d44-b9af-485f12063f06.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Ginkgo Bioworks Holdings, Inc. (DNA)
CIK: 0001830214
Period of Report: 2021-09-16
Reporting Person: SLOAN HARRY (Director)
More from Ginkgo Bioworks Holdings, Inc.
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 5
Director's Dealing
2026
Jan 22
Regulatory Filings
2026
Jan 20
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 23